Gastroenterology
Volume 123, Issue 4 , Pages 1311-1322 , October 2002

Cyclooxygenase-2 gene disruption attenuates the severity of acute pancreatitis and pancreatitis-associated lung injury

Presented in part at the annual meeting of the American Gastroenterological Association in San Diego, California, on May 21–24, 2000, and published in abstract form (Gastroenterology 2000;118:A166).

Received 22 June 2001 ,Accepted 11 July 2002.

References 

  1. Baron TH, Morgan DE. Acute necrotizing pancreatitis. N Engl J Med. 1999;340:1412–1417
  2. Ho HS, Frey CF. Gastrointestinal and pancreatic complications associated with severe pancreatitis. Arch Surg. 1995;130:817–822
  3. Beger HG, Rau B, Mayer J, Pralle U. Natural course of acute pancreatitis. World J Surg. 1997;21:130–135
  4. Saluja AK, Steer MLP. Pathophysiology of pancreatitis. Role of cytokines and other mediators of inflammation. Digestion. 1999;60:27–33
  5. Steinberg W, Tenner S. Acute pancreatitis. N Engl J Med. 1994;330:1198–1210
  6. Ranson JH, Turner JW, Roses DF, Rifkind KM, Spencer FC. Respiratory complications in acute pancreatitis. Ann Surg. 1974;179:557–566
  7. Renner IG, Savage WT, Pantoja JL, Renner VJ. Death due to acute pancreatitis. A retrospective analysis of 405 autopsy cases. Dig Dis Sci. 1985;30:1005–1018
  8. Warshaw AL, Richter JM. A practical guide to pancreatitis. Curr Probl Surg. 1984;21:1–79
  9. Norman J. The role of cytokines in the pathogenesis of acute pancreatitis. Am J Surg. 1998;175:76–83
  10. Denham W, Yang J, Fink G, Denham D, Carter G, Ward K, et al. Gene targeting demonstrates additive detrimental effects of interleukin 1 and tumor necrosis factor during pancreatitis. Gastroenterology. 1997;113:1741–1746
  11. Norman JG, Fink G, Franz M, Guffey J, Carter G, Davison B, et al. Active interleukin-1 receptor required for maximal progression of acute pancreatitis. Ann Surg. 1996;223:163–169
  12. Fu K, Sarras MPJ, De Lisle RC, Andrews GK. Expression of oxidative stress-responsive genes and cytokine genes during caerulein-induced acute pancreatitis. Am J Physiol. 1997;273:G696–G705
  13. Riesle E, Friess H, Zhao L, Wagner M, Uhl W, Baczako K, et al. Increased expression of transforming growth factor-β after acute oedematous pancreatitis in rats suggests a role in pancreatic repair. Gut. 1997;40:73–79
  14. Rongione AJ, Kusske AM, Kwan K, Ashley SW, Reber HA, McFadden DW. Interleukin 10 reduces the severity of acute pancreatitis in rats. Gastroenterology. 1997;112:960–967
  15. Osman MO, Jacobsen NO, Kristensen JU, Deleuran B, Gesser B, Larsen CG, et al. IT 9302, a synthetic interleukin-10 agonist, diminishes acute lung injury in rabbits with acute necrotizing pancreatitis. Surgery. 1998;124:584–592
  16. Hahm KB, Im YH, Lee C, Parks WT, Bang YJ, Green JE, et al. Loss of TGF-beta signaling contributes to autoimmune pancreatitis. J Clin Invest. 2000;105:1057–1065
  17. Gloor B, Todd KE, Lane JS, Rigberg DA, Reber HA. Mechanism of increased lung injury after acute pancreatitis in IL-10 knockout mice. J Surg Res. 1998;80:110–114
  18. Needleman P, Turk J, Jakschik BA, Morrison AR, Lefkowith JB. Arachidonic acid metabolism. Annu Rev Biochem. 1986;55:69–102
  19. Williams CS, DuBois RN. Prostaglandin endoperoxide synthase: why two isoforms?. Am J Physiol. 1996;270:G393–G400
  20. Serou MJ, DeCoster MA, Bazan NG. Interleukin-1 beta activates expression of cyclooxygenase-2 and inducible nitric oxide synthase in primary hippocampal neuronal culture: platelet-activating factor as a preferential mediator of cyclooxygenase-2 expression. J Neurosci Res. 1999;58:593–598
  21. Guan Z, Buckman SY, Miller BW, Springer LD, Morrison AR. Interleukin-1beta-induced cyclooxygenase-2 expression requires activation of both c-Jun NH2-terminal kinase and p38 MAPK signal pathways in rat renal mesangial cells. J Biol Chem. 1998;273:28670–28676
  22. Diaz A, Chepenik KP, Korn JH, Reginato AM, Jimenez SA. Differential regulation of cyclooxygenases 1 and 2 by interleukin-1 beta, tumor necrosis factor-alpha, and transforming growth factor-beta 1 in human lung fibroblasts. Exp Cell Res. 1998;241:222–229
  23. Alaaeddine N, Di Battista JA, Pelletier JP, Kiansa K, Cloutier JM, Martel-Pelletier J. Inhibition of tumor necrosis factor alpha-induced prostaglandin E2 production by the antiinflammatory cytokines interleukin-4, interleukin-10, and interleukin-13 in osteoarthritic synovial fibroblasts: distinct targeting in the signaling pathways. Arthritis Rheum. 1999;42:710–718
  24. Niiro H, Otsuka T, Ogami E, Yamaoka K, Nagano S, Akahoshi M, et al. MAP kinase pathways as a route for regulatory mechanisms of IL-10 and IL-4 which inhibit COX-2 expression in human monocytes. Biochem Biophys Res Commun. 1998;250:200–205
  25. Reddy ST, Gilbert RS, Xie W, Luner S, Herschman HR. TGF-beta 1 inhibits both endotoxin-induced prostaglandin synthesis and expression of the TIS10/prostaglandin synthase 2 gene in murine macrophages. J Leukoc Biol. 1994;55:192–200
  26. Yamamoto K, Arakawa T, Ueda N, Yamamoto S. Transcriptional roles of nuclear factor kappa B and nuclear factor- interleukin-6 in the tumor necrosis factor alpha-dependent induction of cyclooxygenase-2 in MC3T3-E1 cells. J Biol Chem. 1995;270:31315–31320
  27. Newton R, Kuitert LM, Bergmann M, Adcock IM, Barnes PJ. Evidence for involvement of NF-kappaB in the transcriptional control of COX-2 gene expression by IL-1beta. Biochem Biophys Res Commun. 1997;237:28–32
  28. Schmedtje JF, Ji YS, Liu WL, DuBois RN, Runge MS. Hypoxia induces cyclooxygenase-2 via the NF-kappaB p65 transcription factor in human vascular endothelial cells. J Biol Chem. 1997;272:601–608
  29. Steinle AU, Weidenbach H, Wagner M, Adler G, Schmid RM. NF-kappaB/Rel activation in cerulein pancreatitis. Gastroenterology. 1999;116:420–430
  30. Gukovsky I, Gukovskaya AS, Blinman TA, Zaninovic V, Pandol SJ. Early NF-kappaB activation is associated with hormone-induced pancreatitis. Am J Physiol. 1998;275:G1402–G1414
  31. Hietaranta AJ, Saluja AK, Bhagat L, Singh VP, Song AM, Steer ML. Relationship between NF-kappaB and trypsinogen activation in rat pancreas after supramaximal caerulein stimulation. Biochem Biophys Res Commun. 2001;280:388–395
  32. Inoue A, Ikoma K, Morioka N, Kumagai K, Hashimoto T, Hide I, et al. Interleukin-1beta induces substance P release from primary afferent neurons through the cyclooxygenase-2 system. J Neurochem. 1999;73:2206–2213
  33. Bhatia M, Saluja AK, Hofbauer B, Frossard JL, Lee HS, Castagliuolo I, et al. Role of substance P and the neurokinin 1 receptor in acute pancreatitis and pancreatitis-associated lung injury. Proc Natl Acad Sci U S A. 1998;95:4760–4765
  34. Maa J, Grady EF, Yoshimi SK, Drasin TE, Kim EH, Hutter MM, et al. Substance P is a determinant of lethality in diet-induced hemorrhagic pancreatitis in mice. Surgery. 2000;128:232–239
  35. Gomez G, Townsend CM, Green DW, Rajaraman S, Uchida T, Greeley GH, et al. Protective action of luminal bile salts in necrotizing acute pancreatitis in mice. J Clin Invest. 1990;86:323–331
  36. Ethridge RT, Ehlers RA, Hellmich MR, Rajaraman S, Evers BM. Acute pancreatitis results in induction of heat shock proteins 70 and 27 and heat shock factor-1. Pancreas. 2000;21:248–256
  37. Ward JB, Sutton R, Jenkins SA, Petersen OH. Progressive disruption of acinar cell calcium signaling is an early feature of cerulein-induced pancreatitis in mice. Gastroenterology. 1996;111:481–491
  38. Niederau C, Niederau M, Luthen R, Strohmeyer G, Ferrell LD, Grendell JH. Pancreatic exocrine secretion in acute experimental pancreatitis. Gastroenterology. 1990;99:1120–1127
  39. Niederau C, Niederau M, Borchard F, Ude K, Luthen R, Strohmeyer G, et al. Effects of antioxidants and free radical scavengers in three different models of acute pancreatitis. Pancreas. 1992;7:486–496
  40. Langenbach R, Morham SG, Tiano HF, Loftin CD, Ghanayem BI, Chulada PC, et al  Prostaglandin synthase 1 gene disruption in mice reduces arachidonic acid-induced inflammation and indomethacin-induced gastric ulceration. Cell. 1995;83:483–492
  41. Ballou LR, Botting RM, Goorha S, Zhang J, Vane JR. Nociception in cyclooxygenase isozyme-deficient mice. Proc Natl Acad Sci U S A. 2000;97:10272–10276
  42. Ethridge RT, Hellmich MR, DuBois RN, Evers BM. Inhibition of heat-shock protein 70 induction in intestinal cells overexpressing cyclooxygenase 2. Gastroenterology. 1998;115:1454–1463
  43. Evers BM, Zhou Z, Celano P, Li J. The neurotensin gene is a downstream target for Ras activation. J Clin Invest. 1995;95:2822–2830
  44. Schmidt J, Lewandrowski K, Fernandez-del Castillo C, Mandavilli U, Compton CC, Warshaw AL, et al. Histopathologic correlates of serum amylase activity in acute experimental pancreatitis. Dig Dis Sci. 1992;37:1426–1433
  45. Manck JC, Weaver MS, Stanton C. Development of a Kodak Ektadium clinical chemistry slide for serum lipase. (abstr) Clin Chem. 1984;30:1058–1059
  46. Lott JA, Lu CJ. Lipase isoforms and amylase isoenzymes: assays and application in the diagnosis of acute pancreatitis. Clin Chem. 1991;37:361–368
  47. Blinman TA, Gukovsky I, Mouria M, Zaninovic V, Livingston E, Pandol SJ, et al. Activation of pancreatic acinar cells on isolation from tissue: cytokine upregulation via p38 MAP kinase. Am J Physiol. 2000;279:C1993–C2003
  48. Hellmich MR, Rui XL, Hellmich HL, Fleming RY, Evers BM, Townsend CM. Human colorectal cancers express a constitutively active cholecystokinin-B/gastrin receptor that stimulates cell growth. J Biol Chem. 2000;275:32122–32128
  49. Zabel-Langhennig A, Holler B, Engeland K, Mossner J. Cyclooxygenase-2 transcription is stimulated and amylase secretion is inhibited in pancreatic acinar cells after induction of acute pancreatitis. Biochem Biophys Res Commun. 1999;265:545–549
  50. Sorli CH, Zhang HJ, Armstrong MB, Rajotte RV, Maclouf J, Robertson RP. Basal expression of cyclooxygenase-2 and nuclear factor-interleukin 6 are dominant and coordinately regulated by interleukin 1 in the pancreatic islet. Proc Natl Acad Sci U S A. 1998;95:1788–1793
  51. Robertson RP. Dominance of cyclooxygenase-2 in the regulation of pancreatic islet prostaglandin synthesis. Diabetes. 1998;47:1379–1383
  52. Masferrer JL, Zweifel BS, Manning PT, Hauser SD, Leahy KM, Smith WG, et al. Selective inhibition of inducible cyclooxygenase 2 in vivo is antiinflammatory and nonulcerogenic. Proc Natl Acad Sci U S A. 1994;91:3228–3232
  53. Wagner AC, Mazzucchelli L, Miller M, Camoratto AM, Goke B. CEP-1347 inhibits caerulein-induced rat pancreatic JNK activation and ameliorates caerulein pancreatitis. Am J Physiol. 2000;278:G165–G172
  54. Fu JY, Masferrer JL, Seibert K, Raz A, Needleman P. The induction and suppression of prostaglandin H2 synthase (cyclooxygenase) in human monocytes. J Biol Chem. 1990;265:16737–16740
  55. Kujubu DA, Fletcher BS, Varnum BC, Lim RW, Herschman HR. TIS10, a phorbol ester tumor promoter-inducible mRNA from Swiss 3T3 cells, encodes a novel prostaglandin synthase/cyclooxygenase homologue. J Biol Chem. 1991;266:12866–12872
  56. Dinchuk JE, Car BD, Focht RJ, Johnston JJ, Jaffee BD, Covington MB, et al. Renal abnormalities and an altered inflammatory response in mice lacking cyclooxygenase II. Nature. 1995;378:406–409
  57. Morteau O, Morham SG, Sellon R, Dieleman LA, Langenbach R, Smithies O, et al. Impaired mucosal defense to acute colonic injury in mice lacking cyclooxygenase-1 or cyclooxygenase-2. J Clin Invest. 2000;105:469–478
  58. Baciewicz AM, Sokos DR, King TJ. Acute pancreatitis associated with celecoxib. Ann Intern Med. 2000;132:680
  59. Carrillo-Jimenez R, Nurnberger M. Celecoxib-induced acute pancreatitis and hepatitis: a case report. Arch Intern Med. 2000;160:553–554
  60. Runzi M, Layer P. Drug-associated pancreatitis: facts and fiction. Pancreas. 1996;13:100–109
  61. Bartlett SR, Sawdy R, Mann GE. Induction of cyclooxygenase-2 expression in human myometrial smooth muscle cells by interleukin-1β: involvement of p38 mitogen-activated protein kinase. J Physiol (Lond). 1999;520:399–406
  62. Guan Z, Baier LD, Morrison AR. p38 mitogen-activated protein kinase down-regulates nitric oxide and up- regulates prostaglandin E2 biosynthesis stimulated by interleukin-1β. J Biol Chem. 1997;272:8083–8089

☆ Supported by grants from the National Institutes of Health (PO1 DK35608, RO1 DK48498, and T32 DK07639). R.T.E. is a recipient of a National Alpha Omega Alpha Student Research Fellowship and a McLaughlin Fellowship Award. R.A.E. is a recipient of an Individual Research Service Award (F32 CA79187) and a Jeane B. Kempner Award.

☆☆ Address requests for reprints to: B. Mark Evers, M.D., Department of Surgery, University of Texas Medical Branch, 301 University Boulevard, Galveston, Texas 77555-0536. e-mail: mevers@utmb.edu; fax: (409) 747-4819.

PII: S0016-5085(02)00234-2

doi: 10.1053/gast.2002.35951

Gastroenterology
Volume 123, Issue 4 , Pages 1311-1322 , October 2002

Article Tools

* Image Usage & Resolution